Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thioredoxin-1 (Trx-1) is a small, ubiquitous oxidoreductase protein (~12 kDa) that plays a central role in maintaining cellular redox homeostasis by catalyzing the reduction of other proteins. It is involved in antioxidant defense, redox regulation, gene expression, cell proliferation, apoptosis control, and S-nitrosylation. Dysfunction or altered expression has been linked with various diseases including cancer, neurodegenerative disorders, cardiovascular diseases, and inflammatory conditions.
Catalyzes the reduction of other proteins via cysteine thiol-disulfide exchange reactions; modulation of transcription factor activity through redox-dependent mechanisms
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thioredoxin-1 (Trx-1).